Non-Human Primate (NHP) In Vivo Genotoxicity & Carcinogenicity Prediction Service

Are you currently facing complex challenges in predicting the long-term safety and carcinogenic potential of your lead drug candidates? Our Creative Biolabs Non-Human Primate (NHP) In Vivo Toxicology Service helps you de-risk your pipeline and accelerate drug development through a highly predictive preclinical model. We use advanced in vivo toxicology methods and state-of-the-art biological analysis to provide critical insights into your compound's safety profile.

Overview of Non-Human Primate Genotoxicity & Carcinogenicity

In the complex landscape of drug development, accurately predicting a compound's long-term safety is paramount. Non-human primates offer a uniquely valuable model for this task. Due to their close phylogenetic relationship to humans, NHPs share critical similarities in their genetic makeup, immunological responses, and metabolic pathways that are often absent in rodent models. This biological fidelity allows for a more reliable prediction of genotoxic and carcinogenic risk, significantly reducing the uncertainty associated with preclinical data and potentially preventing costly failures in late-stage clinical trials.

What Our Service Is

Our service provides a comprehensive in vivo toxicology assessment focused on genotoxicity and carcinogenicity. This involves administering your compound to a cohort of non-human primates under strict, controlled conditions and monitoring for potential adverse effects over an extended period. This service is essential for:

• Preclinical Safety Assessment: Evaluating the long-term safety of novel drug candidates before they enter human trials.
• Environmental Contaminant Evaluation: Assessing the carcinogenic potential of environmental agents that may pose a long-term risk to human health.

Why Choose Us?

The primary pain point in toxicology is the risk of a compound failing late in development due to unforeseen toxicity, leading to immense financial losses and project delays. By choosing Creative Biolabs, you gain access to a highly predictive model that addresses this challenge head-on. Our NHP studies are designed to provide a higher degree of confidence in your compound's safety profile, allowing you to make informed, data-driven decisions earlier in the development process. The value we create for you is the reduction of risk, ultimately saving you significant time and resources.

Fig.1 Summary of genotoxicity in NHPs and alternative animal models. ¹

Key Benefits of Our Service

Creative Biolabs' In Vivo Toxicology Service offers distinct advantages that set us apart, ensuring your project receives the highest level of scientific rigor and support.

• Accelerated Response Speed: Our streamlined operational protocols and dedicated team of experts ensure a quick initiation and efficient execution of your study, helping you meet your critical development timelines without compromising data quality.
• Unmatched NHP Resources: We maintain a large, healthy, and well-characterized non-human primate colony, which includes but not limited to Cynomolgus, Rhesus, Marmoset, and African Green Monkey, ensuring consistent animal availability and enabling studies of various sizes and durations. This resource base is critical for reliable study outcomes.
• Total Customization: We understand that every project is unique. Our scientific team works closely with you to design a study that is precisely tailored to your compound's specific characteristics and your project's regulatory requirements.
• Unparalleled Reporting Depth: Our final reports are not just data dumps; they are comprehensive, expert-reviewed documents that integrate detailed histopathology, biomarker analysis, and statistical interpretation. Our findings provide you with actionable insights, not just numbers.

How Creative Biolabs' Service Can Assist Your Project?

We provide a clear, step-by-step pathway from initial concept to actionable data. Our structured workflow ensures transparency and collaboration at every stage, providing you with confidence and control throughout your project.

Key Deliverables

Upon completion of your study, you will receive a comprehensive package of deliverables:

• Detailed Lab Report: A complete document detailing the study's methodology, observations, and results.
• Comprehensive Raw Data: All raw data files, including clinical pathology, body weight measurements, and other key metrics.
• Histopathology Images and Annotations: High-resolution digital images of tissue sections with expert annotations and findings.
• Genomic and Molecular Analysis: Data from any specific molecular endpoints, such as gene expression or mutation analysis.

Capabilities & Partnerships

Service-Specific Data

• Annual Sample Size: Over 50,000 samples analyzed per year.
• Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
• Study Pass Rate: 99%+ success rate in meeting study endpoints.

Our Valued Partners

Frequently Asked Questions

Contact Us

Creative Biolabs' In Vivo Toxicology Service for NHPs offers an advanced, predictive framework for evaluating the long-term safety of key drug candidates. With a foundation of expertise, ample resources, and a dedication to scientific excellence, we deliver top-quality data to mitigate risks in your drug pipeline and progress your project with assurance. Connect with our team for further information and to discuss your specific project needs.